InsidersTradesSigma
Biofil Chemicals & Pharmaceuticals Limited: directors' dealings · India · SEBI (PIT + SAST)
SEBI:biofil-chemicals-and-pharmaceuticals-limitedIN·SEBI (PIT + SAST)Mcap 669M€
Explore the full insider trade history of Biofil Chemicals & Pharmaceuticals Limited, a listed issuer based in India. Shares are quoted on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €669.3m. The latest transaction was disclosed on 20 March 2026 (Sale). Among the most active insiders: Niyati Shah. Every trade is openly available.
8
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
3 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
31.92 €
Income statement
Revenue334.0 M€
Gross profit25.6 M€8% margin
Net income5.6 M€1.7% margin
Balance sheet & cash
Market cap669.3 M€
Total debt4.7 M€
Free Cash Flow−20.2 M€
Last declaration on 20 March 2026
Declarations8 total
Executives●Sale2SEBI
032,657 shares
Equity Shares
SEBI:58fc3cf4fccd04738056a826d1bb83b815f9c09d·
Executives●Purchase0SEBI
0493,940 shares
Equity Shares
SEBI:7c839c82e5ccb8ba47c61560bcf026e9d4239be0·
Ideal exit: 3 Mar 2026 (T+270)
Executives●Purchase0SEBI
087,200 shares
Equity Shares
SEBI:84b2f2c28bc7f091cc25537b17bed6bf431b4d3c·
Ideal exit: 6 Dec 2024 (T+270)
Executives●Sale0SEBI
087,200 shares
Equity Shares
SEBI:3d294f85cc1835dcf6a77482eca4b8991c77059e·
Executives●Sale0SEBI
0300,000 shares
Equity Shares
SEBI:dba95ca628068f3fb3ed926615028e82fcae45bd·
Executives●Purchase0SEBI
0300,000 shares
Equity Shares
SEBI:ccc1f575dc760d9a373728a303bd7fb6b62f10f4·
Ideal exit: 26 Dec 2022 (T+270)
Executives●Purchase2SEBI
052,680 shares
Equity Shares
SEBI:06c780a7d421cf8464a16556e647864bb8035d33·
Ideal exit: 29 May 2022 (T+270)
8 of 8 declarations